5,7-Dioxa-6-thiaspiro[2.5]octane 6,6-dioxide, 97%, 250mg

Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate, 95.0%, 10g

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-phenoxytetrahydro-2H-pyran-3,4,5-triol, 95.0%, 1g

8-Oxa-2-azaspiro[4.5]decan-3-one, 95.0%, 1g

4-Isopropylpyridine>98.0%(GC)(T)5g

Ethyl 6-bromo-3-chloro-5-methylpyrazine-2-carboxylate, 95%, 250mg

2-[(4-chlorophenyl)methoxy]benzoic acid, 95%, 500mg

2-(Trifluoromethyl)pyrimidine-4-carboxylic acid, 95.0%, 100mg

5,6-Dibromo-1,10-phenanthroline, 95%, 1g

Thalidomide-NH-PEG4-COOH, 50mg

1-Bromo-4,5-difluoro-3-ethoxybenzene, 97.0%, 25g

DL-asparagine monohydrate, min. 98%, for biochemistry, 250 g, plastic packaging.

1-(2-hydroxyethyl)-3,5-dimethyl-1H-pyrazole-4-carbaldehyde, 95.0%, 250mg